• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.26% Nasdaq Down0.34%

    More On AMF.TO

    Amorfix Life Sciences Ltd. (AMF.TO)

    0.04 0.00(0.00%) 3:53PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Amorfix Life Sciences Ltd.
    3403 American Drive
    Mississauga, ON L4V 1T4
    Canada - Map
    Phone: 416-847-6898
    Fax: 416-847-6899
    Website: http://www.amorfix.com

    Index Membership:N/A
    Industry:Medical Laboratories & Research
    Full Time Employees:N/A

    Business Summary 

    Amorfix Life Sciences Ltd. develops therapeutic products and diagnostic devices for misfolded protein diseases in Canada. It develops antibodies and vaccines for the treatment of Amyotrophic Lateral Sclerosis (ALS) and various types of cancer. The company's diagnostic programs include EP-AD CSF Diagnostic Test, an assay for the detection of the aggregated form of Aß in human cerebrospinal fluid and mild cognitive impairment; A4, an ultra-sensitive assay for detecting aggregated Aß in animal models of Alzheimer's disease (AD); blood test for use as a diagnostic tool for ALS; and ProMIS, a computer based algorithm that predicts disease specific epitopes. It also offers custom assay development services. The company also has strategic alliances with Epitomics Inc. to develop immunotherapeutics to various proteins; and license agreement with Biogen Idec for developing therapeutics to treat ALS. Amorfix Life Sciences Ltd. is headquartered in Mississauga, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Amorfix Life Sciences Ltd.

    Key Executives 
    Dr. Robert H. Gundel Ph.D., M.B.A., 60
    Chief Exec. Officer, Pres, Non Independent Director and Member of Financing Committee
    Dr. Neil Cashman M.D.,
    Founder, Chief Scientific Officer, Chairman of Scientific Advisory Board, Non Independent Director and Member of Financing Committee
    Mr. Warren Whitehead C.M.A., 63
    Chief Financial Officer and Director
    Louise Scrocchi ,
    Associate Director of R&D
    Ms. Lynda P. S. Covello LLB, LLM.,
    VP of Strategic Alliances
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.
    View Insiders